PMC:7096774 / 6602-7546
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 143 | 167-177 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 144 | 280-287 | Species | denotes | patient | Tax:9606 |
| 145 | 298-308 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 146 | 592-597 | Species | denotes | human | Tax:9606 |
| 147 | 384-391 | Chemical | denotes | acetone | MESH:D000096 |
| 148 | 542-568 | Chemical | denotes | fluorescein isothiocyanate | |
| 149 | 570-574 | Chemical | denotes | FITC | |
| 150 | 249-257 | Disease | denotes | infected | MESH:D007239 |
| 151 | 240-242 | CellLine | denotes | E6 | CVCL:4582 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T42 | 0-5 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
| T43 | 130-135 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T44 | 136-139 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T45 | 144-147 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T46 | 243-248 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T47 | 404-409 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
| T48 | 486-489 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T49 | 505-508 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T50 | 510-520 | Body_part | denotes | Antibodies | http://purl.org/sig/ont/fma/fma62871 |
| T51 | 598-601 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T52 | 605-608 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T53 | 694-697 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T54 | 730-733 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T55 | 802-807 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T9 | 0-5 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T10 | 130-135 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T11 | 404-409 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T12 | 802-807 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T41 | 167-175 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T42 | 298-306 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T39 | 235-248 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
| T40 | 324-329 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T41 | 592-597 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T46 | 384-391 | Chemical | denotes | acetone | http://purl.obolibrary.org/obo/CHEBI_15347 |
| T47 | 542-568 | Chemical | denotes | fluorescein isothiocyanate | http://purl.obolibrary.org/obo/CHEBI_37926 |
| T48 | 542-553 | Chemical | denotes | fluorescein | http://purl.obolibrary.org/obo/CHEBI_31624 |
| T49 | 554-568 | Chemical | denotes | isothiocyanate | http://purl.obolibrary.org/obo/CHEBI_52221 |
| T50 | 570-574 | Chemical | denotes | FITC | http://purl.obolibrary.org/obo/CHEBI_37926 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T62 | 0-117 | Sentence | denotes | Serum samples were collected from the index case on Days 4, 9, 10 and 20 from onset of the first symptoms (Figure 1). |
| T63 | 118-403 | Sentence | denotes | Presence of serum IgM and IgG antibodies against SARS-CoV-2 was analysed by immunofluorescence assays (IFA) based on Vero E6 cells infected with passage 4 of the patient’s isolate SARS-CoV-2/Finland/1/2020 virus and transferred onto microscope slides and fixed with acetone (Figure 2). |
| T64 | 404-509 | Sentence | denotes | Serum samples from the index case were serially diluted and incubated for 2 h for IgM and 30 min for IgG. |
| T65 | 510-620 | Sentence | denotes | Antibodies were visualised with fluorescein isothiocyanate (FITC)-conjugated anti-human IgM or IgG antibodies. |
| T66 | 621-794 | Sentence | denotes | While the antibodies were undetectable on Day 4 after onset of symptoms, IgG titres rose to 80 and 1,280 and IgM titres to 80 and 320 on Days 9 and 20, respectively (Table). |
| T67 | 795-944 | Sentence | denotes | Random serum samples from staff members of the University of Helsinki (n = 19) did not show specific binding at dilutions greater than 20 (Figure 2). |